Platelet-rich fibrin (PRF) is a type of biomaterial extracted from the blood that has a larger concentration of platelets, white blood cells, and stem cells than normal blood. It differs from platelet-rich plasma as it contains fibrin, an insoluble protein matrix, that helps to keep platelets in place around an injury.
Platelet-rich fibrin (PRF) therapy is the newest addition to the field of regenerative medicine. It involves the injection of platelet-rich fibrin derived from your own blood to optimize the healing of wounds and injuries. It is considered a more advanced alternative to platelet-rich plasma (PRP) as it has a higher concentration of platelets and in many cases, PRF is replacing steroid injections due to its longer-lasting effects and its lower risk profile.
As the platelet-rich-fibrin is obtained from your own body, there are hardly any adverse effects from the procedure. However, there is a minimal risk of pain, swelling, and infection at the injection site.